Development
Ekso Bionics Holdings, Inc.
EKSO
$3.14
-$0.11-3.39%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -3.21M | -3.37M | -4.23M | -4.39M | -3.18M |
| Total Depreciation and Amortization | 675.00K | 342.00K | 267.00K | 414.00K | 258.00K |
| Total Amortization of Deferred Charges | -243.00K | 82.00K | 161.00K | -- | -3.00K |
| Total Other Non-Cash Items | 284.00K | 908.00K | 510.00K | 327.00K | -362.00K |
| Change in Net Operating Assets | 914.00K | -1.32M | 389.00K | -566.00K | -359.00K |
| Cash from Operations | -1.58M | -3.35M | -2.90M | -4.21M | -3.64M |
| Capital Expenditure | -43.00K | -17.00K | -55.00K | -42.00K | -53.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 19.00K |
| Cash Acquisitions | -- | -- | -- | -- | -5.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -43.00K | -17.00K | -55.00K | -42.00K | -5.03M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -313.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 661.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 348.00K | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -20.00K | 0.00 | -12.00K | 8.00K | 23.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.30M | -3.37M | -2.97M | -4.25M | -8.66M |